GlassScriptPhysician profile
Gregory Hubbs
NPI 1568798973
$2,147.50
in general payments reported to CMS, 2019-2025
11 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.55 · 2022: $513 · 2023: $551 · 2024: $612 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,536.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $635.84 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $324.50 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $279.11 | 2022-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $258.01 | 2021-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $242.05 | 2022-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Abiomed | $193.02 | 2024-2025 | Impella |
| Pfizer INC. | $81.70 | 2022-2024 | |
| Boston Scientific Corporation | $50.18 | 2022-2023 | Watchman Access System |
| Chiesi USA, INC. | $36.08 | 2024-2025 | Cleviprex, Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.17 | 2021 | |
| Edwards Lifesciences Corporation | $12.84 | 2023 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Hubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.